Sanofi Chief Executive Paul Hudson said on Monday that the company has not made a final decision yet on how it plans to split ...

[10] Conti P, Kempuraj D. Important role of mast cells in multiple sclerosis. Mult Scler Relat Disord. 2016;5:77-80. [11] Skaper SD, Facci L, Giusti P. Mast cells, glia and neuroinflammation: partners ...

B.Riley Financial analyst William Wood has reiterated their bullish stance on IMUX stock, giving a Buy rating on September 16. William Wood ...

As usual, a second trial will be needed before UCB and Biogen can file dapirolizumab pegol with regulators. It will be called ...

Biogen markets several multiple sclerosis drugs including Plegridy ... Biogen has several drug candidates in phase 3 trials ...

Today is an important day for Cardarelli as it inaugurates a department dedicated to patients with multiple sclerosis. We ...

Sanofi to receive an exclusive right of first negotiation for Ventyx’s CNS-penetrant NLRP3 inhibitor VTX3232SAN DIEGO, Sept. 23, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: VTYX) (“Ventyx”), a clinical-stage ...

“If not treated early upon diagnosis, multiple sclerosis can lead to significant ... senior vice president and head of clinical development, Immunology, Cardiovascular and Neuroscience, Bristol Myers ...

More and more research suggests that gut microbiome metabolites could hold the key to treating nearly every disease.

Abu Dhabi Stem Cells Center (ADSCC) and Burjeel Holdings, a leading super-specialty healthcare services provider in MENA, ...

He also was Chairman of the Interdepartmental Immunology Program at Stanford from 2002-2011. He is a member of the National Academy of Sciences and the National Academy of Medicine. Steinman is ...